1. Bu J, Wu Y, Cai X, Jiang N, Jeyalatha MV, Yu J, He X, He H, Guo Y, Zhang M et al. Hyperlipidemia induces meibomian gland dysfunction. Ocul Surf. 2019;17(4):777-786.
2. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN. The international workshop on meibomian gland dysfunction: Report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):1930-1937.
3. Nichols KK. The international workshop on meibomian gland dysfunction: Introduction. Invest Ophthalmol Vis Sci. 2011;52(4):1917-1921.
4. Cooper ID. Bibliometrics basics. J Med Libr Assoc. 2015;103(4):217-218.
5. van Eck NJ, Waltman L. Software survey: Vosviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523-538.
6. Chen C, Dubin R, Kim MC. Emerging trends and new developments in regenerative medicine: A scientometric update (2000 - 2014). Expert Opin Biol Ther. 2014;14(9):1295-1317.
7. Zhao F, Du F, Shi D, Zhou W, Jiang Y, Ma L. Mapping research trends of retinal vein occlusion from 2009 to 2018: A bibliometric analysis. PeerJ. 2019;7:e7603.
8. Arita R, Mori N, Shirakawa R, Asai K, Imanaka T, Fukano Y, Nakamura M. Linoleic acid content of human meibum is associated with telangiectasia and plugging of gland orifices in meibomian gland dysfunction. Exp Eye Res. 2016;145:359-362.
9. Mizoguchi S, Iwanishi H, Arita R, Shirai K, Sumioka T, Kokado M, Jester JV, Saika S. Ocular surface inflammation impairs structure and function of meibomian gland. Exp Eye Res. 2017;163:78-84.
10. Jun I, Kim BR, Park SY, Lee H, Kim J, Kim EK, Seo KY, Kim TI. Interleukin-4 stimulates lipogenesis in meibocytes by activating the stat6/pparγ signaling pathway. Ocul Surf. 2020;18(4):575-582.
11. Arita R, Mizoguchi T, Fukuoka S, Morishige N. Multicenter study of intense pulsed light therapy for patients with refractory meibomian gland dysfunction. Cornea. 2018;37(12):1566-1571.
12. Arita R, Kawashima M, Ito M, Tsubota K. Clinical safety and efficacy of vitamin d3 analog ointment for treatment of obstructive meibomian gland dysfunction. BMC Ophthalmol. 2017;17
13. Lee H, Kim M, Park SY, Kim EK, Seo KY, Kim TI. Mechanical meibomian gland squeezing combined with eyelid scrubs and warm compresses for the treatment of meibomian gland dysfunction. Clin Exp Optom. 2017;100(6):598-602.
14. Arita R, Minoura I, Morishige N, Shirakawa R, Fukuoka S, Asai K, Goto T, Imanaka T, Nakamura M. Development of definitive and reliable grading scales for meibomian gland dysfunction. Am J Ophthalmol. 2016;169:125-137.
15. Arita R, Itoh K, Maeda S, Maeda K, Amano S. A newly developed noninvasive and mobile pen-shaped meibography system. Cornea. 2013;32(3):242-247.
16. Ambaw YA, Fuchs D, Raida M, Mazengia NT, Torta F, Wheelock CE, Wenk MR, Tong L. Changes of tear lipid mediators after eyelid warming or thermopulsation treatment for meibomian gland dysfunction. Prostaglandins Other Lipid Mediat. 2020;151:106474.
17. Ambaw YA, Chao C, Ji S, Raida M, Torta F, Wenk MR, Tong L. Tear eicosanoids in healthy people and ocular surface disease. Sci Rep. 2018;8(1):11296.
18. Han X, Liu Y, Kam WR, Sullivan DA. Effect of brimonidine, an α2 adrenergic agonist, on human meibomian gland epithelial cells. Exp Eye Res. 2018;170:20-28.
19. Liu Y, Kam WR, Fernandes P, Sullivan DA. The effect of solithromycin, a cationic amphiphilic drug, on the proliferation and differentiation of human meibomian gland epithelial cells. Curr Eye Res. 2018;43(6):683-688.
20. Wang MTM, Muntz A, Lim J, Kim JS, Lacerda L, Arora A, Craig JP. Ageing and the natural history of dry eye disease: A prospective registry-based cross-sectional study. Ocul Surf. 2020;18(4):736-741.
21. Wang MTM, Vidal-Rohr M, Muntz A, Diprose WK, Ormonde SE, Wolffsohn JS, Craig JP. Systemic risk factors of dry eye disease subtypes: A new zealand cross-sectional study. Ocul Surf. 2020;18(3):374-380.
22. Liu S, Richards SM, Lo K, Hatton M, Fay A, Sullivan DA. Changes in gene expression in human meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011;52(5):2727-2740.
23. Powell DR, Nichols JJ, Nichols KK. Inter-examiner reliability in meibomian gland dysfunction assessment. Invest Ophthalmol Vis Sci. 2012;53(6):3120-3125.
24. Wang MTM, Feng J, Wong J, Turnbull PR, Craig JP. Randomised trial of the clinical utility of an eyelid massage device for the management of meibomian gland dysfunction. Cont Lens Anterior Eye. 2019;42(6):620-624.
25. Borchman D, Ramakrishnan V, Henry C, Ramasubramanian A. Differences in meibum and tear lipid composition and conformation. Cornea. 2020;39(1):122-128.
26. Borchman D, Ramasubramanian A, Foulks GN. Human meibum cholesteryl and wax ester variability with age, sex, and meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2019;60(6):2286-2293.
27. Nencheva Y, Ramasubramanian A, Eftimov P, Yokoi N, Borchman D, Georgiev GA. Effects of lipid saturation on the surface properties of human meibum films. Int J Mol Sci. 2018;19(8)
28. Borchman D, Foulks GN, Yappert MC, Milliner SE. Differences in human meibum lipid composition with meibomian gland dysfunction using nmr and principal component analysis. Invest Ophthalmol Vis Sci. 2012;53(1):337-347.
29. Foulks GN, Borchman D, Yappert M, Kakar S. Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: A comparative clinical and spectroscopic pilot study. Cornea. 2013;32(1):44-53.
30. Borchman D. The optimum temperature for the heat therapy for meibomian gland dysfunction. Ocul Surf. 2019;17(2):360-364.
31. Knop E, Knop N, Millar T, Obata H, Sullivan DA. The international workshop on meibomian gland dysfunction: Report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci. 2011;52(4):1938-1978.
32. Suhalim JL, Parfitt GJ, Xie Y, De Paiva CS, Pflugfelder SC, Shah TN, Potma EO, Brown DJ, Jester JV. Effect of desiccating stress on mouse meibomian gland function. Ocul Surf. 2014;12(1):59-68.
33. Arita R, Kawashima M, Ito M, Tsubota K. Clinical safety and efficacy of vitamin d3 analog ointment for treatment of obstructive meibomian gland dysfunction. BMC Ophthalmol. 2017;17(1):84.
34. Borchman D, Ramasubramanian A. Human meibum chain branching variability with age, gender and meibomian gland dysfunction. Ocul Surf. 2019;17(2):327-335.
35. Ibrahim OM, Dogru M, Matsumoto Y, Igarashi A, Kojima T, Wakamatsu TH, Inaba T, Shimizu T, Shimazaki J, Tsubota K. Oxidative stress induced age dependent meibomian gland dysfunction in cu, zn-superoxide dismutase-1 (sod1) knockout mice. PLoS One. 2014;9(7):e99328.
36. Arita R, Mizoguchi T, Kawashima M, Fukuoka S, Koh S, Shirakawa R, Suzuki T, Morishige N. Meibomian gland dysfunction and dry eye are similar but different based on a population-based study: The hirado-takushima study in japan. Am J Ophthalmol. 2019;207:410-418.
37. Arita R. Meibography: A japanese perspective. Invest Ophthalmol Vis Sci. 2018;59(14)
38. Randon M, Aragno V, Abbas R, Liang H, Labbé A, Baudouin C. In vivo confocal microscopy classification in the diagnosis of meibomian gland dysfunction. Eye (Lond). 2019;33(5):754-760.
39. Liang Q, Pan Z, Zhou M, Zhang Y, Wang N, Li B, Baudouin C, Labbé A. Evaluation of optical coherence tomography meibography in patients with obstructive meibomian gland dysfunction. Cornea. 2015;34(10):1193-1199.
40. Shtein RM, Shen JF, Kuo AN, Hammersmith KM, Li JY, Weikert MP. Autologous serum-based eye drops for treatment of ocular surface disease: A report by the american academy of ophthalmology. Ophthalmology. 2020;127(1):128-133.
41. Piyacomn Y, Kasetsuwan N, Reinprayoon U, Satitpitakul V, Tesapirat L. Efficacy and safety of intense pulsed light in patients with meibomian gland dysfunction-a randomized, double-masked, sham-controlled clinical trial. Cornea. 2020;39(3):325-332.
42. Liu R, Rong B, Tu P, Tang Y, Song W, Toyos R, Toyos M, Yan X. Analysis of cytokine levels in tears and clinical correlations after intense pulsed light treating meibomian gland dysfunction. Am J Ophthalmol. 2017;183:81-90.
43. Epitropoulos AT, Donnenfeld ED, Shah ZA, Holland EJ, Gross M, Faulkner WJ, Matossian C, Lane SS, Toyos M, Bucci FA, Jr. et al. Effect of oral re-esterified omega-3 nutritional supplementation on dry eyes. Cornea. 2016;35(9):1185-1191.
44. Fukuoka S, Arita R. Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: A randomized clinical study. Sci Rep. 2019;9(1):9091.
45. Ma X, Lu Y. Efficacy of intraductal meibomian gland probing on tear function in patients with obstructive meibomian gland dysfunction. Cornea. 2016;35(6):725-730.
46. Hassanzadeh S, Varmaghani M, Zarei-Ghanavati S, Heravian Shandiz J, Azimi Khorasani A. Global prevalence of meibomian gland dysfunction: A systematic review and meta-analysis. Ocul Immunol Inflamm. 2020:1-10.
47. Craig JP, Wang MTM, Ambler A, Cheyne K, Wilson GA. Characterising the ocular surface and tear film in a population-based birth cohort of 45-year old new zealand men and women. Ocul Surf. 2020;18(4):808-813.